Skip to main content
OpenTrials
Completed

NCT Number: NCT04189068

Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic Acid

this study discussed the pathogenesis, treatment, and prognosis of severe cerebral infarction and ophthalmic artery occlusion for Aisan induced by hyalruonic acid filler injection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Magnetic Resonance Angiography

Sex eligibility

All sexes

Study type

Observational

Primary location

Qing

Xi'an, Shaan XI Province, 710032, China

About this study

Intra-arterial thrombolysis and retrobulbar injection of hyaluronidase have been used for HA-induced ophthalmic artery obstruction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of cerebral infarction

Exclusion criteria

  • fat embolism

Treatment and study plan

Primary outcomes

  1. pulse

    Time frame: 0-6 day

    Monitore the "beats per minute over the past 6 days.

  2. blood pressure

    Time frame: 0-6 day

    Monitor the blood pressure and record with mm Hg over the past 6 days.

Sponsors and collaborators

Lead sponsor

Xijing Hospital

Other

Registry information

Official study title

Fatal Cerebral Infarction and Ophthalmic Artery Occlusion After Nasal Augmentation With Hyaluronic Acid - A Case Report and Review

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Dec 6, 2019
Registry last updated
Dec 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.